No association of the NFKB1 promoter polymorphism with ulcerative colitis in a British case control cohort [5]

Gut

Volumn 54, Issue 8, 2005, Pages 1205-1206

  Mirza, M M ^a   Fisher, S A ^a   Onnie, C ^a   Lewis, C M ^a   Mathew, C G ^a,d   Sanderson, J ^b   Forbes, A ^c  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b ST THOMAS HOSPITAL   (United Kingdom)

^c ST MARK S HOSPITAL   (United Kingdom)

^d GUY S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;

CONTROLLED STUDY; DNA POLYMORPHISM; ENTERITIS; GENE; GENE DELETION; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; HUMAN; LETTER; MAJOR CLINICAL STUDY; NFKB1 GENE; PRIORITY JOURNAL; PROMOTER REGION; ULCERATIVE COLITIS;

CASE-CONTROL STUDIES; COLITIS, ULCERATIVE; GENOTYPE; HUMANS; NF-KAPPA B P50 SUBUNIT; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); TRANSCRIPTION FACTORS;

EID: 22644446954     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.2005.070029     Document Type: Letter

References (10)

1. Karban AS, Okazaki T, Panhuysen CI, et al. Functional annotation of a novel NFKB1 promoter polymorphism that increases risk for ulcerative colitis. Hum Mol Genet 2004;13:35-45.
2. Bonizzi G, Karin M. The two NF-kB activation pathways and their role in innate and adaptive immunity. Trends Immunol 2004;25:280-8.
3. Hampe J, Schreiber S, Shaw SH, et al. A genomewide analysis provides evidence for novel linkages in inflammatory bowel disease in a large European cohort. Am J Hum Genet 1999;64:808-16.
4. Cho JH, Nicolae DL, Gold LH, et al. Identification of novel susceptibility loci for inflammatory bowel disease on chromosomes 1p, 3q, and 4q: evidence for epistasis between 1p and IBD1. Proc Natl Acad Sci U S A 1998;95:7502-7.
5. Rioux JD, Silverberg MS, Daly MJ, et al. Genomewide search in Canadian families with inflammatory bowel disease reveals two novel susceptibility loci. Am J Hum Genet 2000;66:1863-70.
6. Cuthbert AP, Fisher SA, Mirza MM, et al. The contribution of NOD2 gene mutations to the risk and site of disease in inflammatory bowel disease. Gastroenterology 2002;122:867-74.
7. Lewis CM. Genetic association studies: design, analysis and interpretation. Brief Bioinform 2002;3:146-53.
8. Colhoun HM, McKeigue PM, Davey Smith G. Problems of reporting genetic associations with complex outcomes. Lancet 2003;361:865-72.
9. Matnew CG, Lewis CM. Genetics of inflammatory bowel disease: progress and prospects. Hum Mol Genet 2004;13:R161-8.
10. Ioannidis JP, Ntzani EE, Trikalinos TA, et al. Replication validity of genetic association studies. Nat Genet 2001;29:306-9.